Iveda Solutions, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, reporting financial results for both the three and nine months ended on that date.

Key Highlights

  • Nine-month net loss: The company reported a net loss of $2,175,153 for the nine months ended September 30, 2026, compared to a net loss of $1,579,225 for the same period in 2025.
  • Third-quarter net loss: Net loss for the three months ended September 30, 2026 was $848,853, compared to $221,304 in the prior-year quarter.
  • Total revenue declined: Nine-month total revenue was $3,919,403, down from $4,654,270 in the nine months ended September 30, 2025.
  • Share count increased: Common shares outstanding grew to 13,354,739 as of November 10, 2026, from 5,879,741 as of December 31, 2025.
  • Cash position: Cash and cash equivalents stood at $3,880,414 as of September 30, 2026, compared to $5,156,252 at December 31, 2025.
  • Accumulated deficit: The accumulated deficit reached $58,549,982 as of September 30, 2026, up from $56,374,829 at December 31, 2025.
  • Gross profit improvement: Nine-month gross profit was $1,511,990, compared to $1,250,258 in the prior-year period, according to the filing.

Iveda Solutions Financial Results: Revenue, Losses, and Equity Changes Through September 30, 2026

According to the filing, Iveda Solutions (NASDAQ:IVDA) reported total revenue of $1,623,383 for the three months ended September 30, 2026, a slight decrease from $1,651,787 in the same quarter of 2025. Revenue consisted of equipment sales of $1,501,983 and service revenue of $121,400 for the quarter. For the nine-month period, equipment sales were $3,644,566 and service revenue was $274,837, bringing total nine-month revenue to $3,919,403.

The filing disclosed that total operating expenses for the nine months ended September 30, 2026 were $3,589,383, up from $2,832,479 in the comparable prior-year period. General and administrative expenses accounted for $3,407,876 of that total, compared to $2,722,229 in the prior nine months. Research and development expenses were $181,507 for the nine months, versus $110,250 in the year-earlier period. The loss from operations for the nine months was reported as $2,077,393, compared to $1,582,221 in the nine months ended September 30, 2025.

The company's stockholders' equity as of September 30, 2026 was $4,847,417, compared to $4,779,762 at December 31, 2025, the filing stated. During the nine-month period, the company raised proceeds through warrant exercises and stock issuances. Specifically, the filing shows 5,714,286 shares were sold in the first quarter of 2026, and additional shares were issued through warrant exercises of 825,000 and 835,712 shares in the second and third quarters, respectively. Common stock for services of 100,000 shares was also issued in the second quarter. Total assets as of September 30, 2026 were $6,891,391, up from $6,427,790 at December 31, 2025. The basic and diluted loss per share for the nine months ended September 30, 2026 was $(0.19), compared to $(0.54) for the same period in 2025, based on weighted average shares of 11,265,827 and 2,897,887, respectively.

What Was Disclosed

Iveda Solutions filed its quarterly report covering the period ended September 30, 2026, disclosing a nine-month net loss of $2,175,153, reduced total revenue compared to the prior year, increased operating expenses, and a share count that roughly doubled from December 31, 2025 to November 10, 2026.